Financhill
Back

Medacta Group SA Quote, Financials, Valuation and Earnings

Medacta Group SA Price Quote

$83.91

Medacta Group SA Key Stats

Sell
33
Medacta Group SA (MEDGF) is a Sell

Day range:
$83.91 - $83.91
52-week range:
$83.91 - $83.91
Dividend yield:
0.72%
P/E ratio:
32.70
P/S ratio:
2.86
P/B ratio:
4.54%

Volume:
0
Avg. volume:
0
1-year change:
0%
Market cap:
$1.7B
Revenue:
$553M
EPS:
$3.03

How Much Does Medacta Group SA Make?

Is Medacta Group SA Growing As A Company?

Data Unavailable

Medacta Group SA Stock Price Performance

What Is Medacta Group SA 52-Week High & Low?

Medacta Group SA Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Medacta Group SA?

  • How Much Debt Does Medacta Group SA Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medacta Group SA Have?
    Cash and short term investments quarterly total is $23.2M
  • What Is Medacta Group SA’s Book Value Per Share?
    Book value per share is 18.49

Is Medacta Group SA Cash Flow Positive?

  • What Is MEDGF Cash Flow From Operations?
    Cash flow from operations (TTM) is $85.6M
  • What Is Medacta Group SA’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $578.7K
  • What Is Medacta Group SA’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$98.9M

Medacta Group SA Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDGF return on invested capital is 14.7%
  • What Is Medacta Group SA Return On Assets?
    ROA measures how assets are converting to revenues and is 8.06%
  • What Is MEDGF Return On Equity?
    ROE is a measure of profitability and is 17.18%

Medacta Group SA Earnings Date & Stock Price

Medacta Group SA Competitors

  • Who Are Medacta Group SA's Competitors?
    Below is a list of companies who compete with Medacta Group SA or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

Medacta Group SA Dividend Yield

Medacta Group SA Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many MEDGF shares are owned by institutional investors?
    3M MEDGF shares are owned by institutional investors
  • How many MEDGF shares are owned by insiders?
    1.5B MEDGF shares are owned by insiders